mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |
mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
0.062 |
0.06 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.06 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.084 |
0.06 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.059 |
0.07 |
mRNA |
MK-2206 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.08 |